Peptide Recommendations

Semaglutide is a GLP-1 medication commonly used for appetite control, fullness, and medically supervised weight loss. In GlowStrong, it belongs in the weight-management pathway for users struggling with hunger, food noise, portions, or regain risk.

Tirzepatide is a GLP-1/GIP medication that fits users seeking strong appetite, fullness, and weight-loss support. In the scan, it matches people with regain risk, cravings, plateaus, or a need for more structured medical weight-loss support.

Retatrutide is a next-generation obesity drug candidate discussed because it targets multiple metabolic hormone pathways. GlowStrong should treat it as education for advanced medication interest, not as a normal public product recommendation.

AOD-9604 is commonly discussed for fat-loss and body-composition interest. In GlowStrong it should be framed as education for users asking about stubborn fat or body recomposition, not as a replacement for GLP-1 therapy, nutrition, or training.

Cagrilintide is an amylin-pathway drug candidate discussed for appetite, fullness, and weight-management support. It fits users who want to understand what may come after or alongside GLP-1 medications, especially combination-style metabolic care.

Survodutide is discussed as a dual GLP-1/glucagon pathway option. In GlowStrong, it belongs in next-generation metabolic education for users interested in obesity, liver/metabolic health, and future medication classes.

Mazdutide is a dual GLP-1/glucagon medication discussed for weight and metabolic health. For GlowStrong, it should be shown as regional/advanced metabolic education rather than a standard product recommendation.

VK2735 is a pipeline obesity drug candidate discussed because it targets GLP-1 and GIP pathways. GlowStrong should use it for education when users ask about future weight-loss medications or alternatives to current GLP-1/GIP options.

BPC-157 is commonly discussed for soft-tissue recovery, joint discomfort, and healing support. GlowStrong should explain the interest while steering users toward provider review and rehab fundamentals.

TB-500 is commonly discussed for injury repair, mobility, and recovery. GlowStrong should position it as provider-reviewed education because diagnosis, product quality, and safety screening matter.

KPV is commonly discussed around inflammation, gut comfort, and immune balance. It fits users whose scan shows gut issues, inflammatory concerns, recovery barriers, or immune-resilience interest.

Tesamorelin is best explained as a visceral-fat and growth-hormone-axis medication, not a casual weight-loss peptide. It may matter for users focused on abdominal/visceral fat and body composition, but eligibility is narrow.

Ipamorelin is commonly discussed for recovery, sleep quality, and growth-hormone signaling. GlowStrong should use it for GH-axis education and require provider screening before any active protocol.

CJC-1295 is discussed for GH-axis support, recovery, sleep, and body composition. It should be separated from Ipamorelin in the product library so users can understand the role of each option.

Sermorelin is discussed for growth-hormone release, recovery, sleep, and vitality. It fits users who want a more measured GH-axis education path and understand that labs and medical review matter.

MOTS-c is commonly discussed for cellular energy, metabolic flexibility, exercise capacity, and healthy-aging goals. In GlowStrong, it fits users asking for energy and metabolism support beyond weight alone.

GHK-Cu is a copper peptide often discussed for skin quality, hair appearance, elasticity, and healthy-aging aesthetics. It is a natural fit for weight-loss users worried about hair shedding or visible body changes.

Thymosin Alpha-1 is discussed for immune resilience and wellness support. GlowStrong should use it for immune-support education, especially when users select inflammation, recovery, or resilience goals.

Kisspeptin-10 is best positioned as hormone and reproductive-axis education. It should not feel like a casual libido product because hormones, fertility, medications, and labs require clinical review.

PT-141 is discussed for sexual wellness and desire. GlowStrong should explain that it has a prescription context for a specific indication while avoiding casual performance claims or generalized self-use instructions.